Prosecution Insights
Last updated: April 19, 2026

National Cancer Center

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19177218 TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Final Rejection Apr 11, 2025
18583630 ENDOSCOPE SYSTEM, METHOD FOR CONTROLLING ENDOSCOPE SYSTEM, AND RECORDING MEDIUM FAIRCHILD, AARON BENJAMIN 3795 Non-Final OA Feb 21, 2024
18260186 TRIPLE QUADRUPOLE-BASED MULTIPLE REACTION MONITORING FOR CLINICAL THERAPEUTIC RESPONSE PREDICTION IN CANCER MUI, CHRISTINE T 1797 Non-Final OA Sep 22, 2023
18250913 APPLICATION OF PREVOTELLA STERCOREA STRAIN FOR CANCER PREVENTION OR TREATMENT ARMATO JR, DENNIS IGNATIUS 1651 Non-Final OA Apr 27, 2023
18248706 INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM OMETZ, DAVID LOUIS 2672 Non-Final OA Apr 12, 2023
18105300 ENDOSCOPE SYSTEM, CONTROLLER, CONTROL METHOD, AND RECORDING MEDIUM ABBASI, ABDUL HADI 3795 Final Rejection Feb 03, 2023
17904926 METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS BELYAVSKYI, MICHAIL A 1644 Non-Final OA Aug 24, 2022

Managing National Cancer Center's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month